Merck
Provides life science materials and technologies including bioinks and 3D printing solutions for pharmaceutical and bioprinting applications, enabling personalized medicine and drug development.
- CEO / Founder
- Belén Garijo
- Team Size
- 10000+
- Stage
- Active
Technology & Products
Key Products
Bioinks; 3D printing materials for tablets; Life science reagents; Pharmaceutical development tools
Technological Advantage
Proprietary materials and processes for bioprinting and pharmaceutical 3D printing, supported by a global R&D network and regulatory expertise in GMP standards.
Differentiation
Value Proposition
Accelerates drug development and bioprinting research through high-quality materials and integrated 3D printing technologies, reducing time-to-market for therapies and enabling customized formulations.
How They Differentiate
Offers a broad portfolio of 300,000+ life science products combined with 3D printing capabilities, unlike pure-play bioprinting startups, providing integrated solutions from materials to manufacturing.
Market & Competition
Target Customers
Pharmaceutical companies, research institutions, biotech firms, and academic labs
Industry Verticals
Pharmaceutical; Biotechnology; Medical Research; Healthcare
Competitors
Cellink; Organovo; Allevi
Growth & Milestones
Growth Metrics
Merck's Life Science business, which includes bioprinting and 3D cell culture products, reported sales growth of 6.4% in 2023, with the Process Solutions segment (encompassing bioprocessing and related technologies) showing strong demand driven by advancements in personalized medicine and drug development.
Major Milestones
2015: Merger of Merck Millipore and Sigma-Aldrich; 2020: Partnership with AMCM for 3D-printed tablets; Establishment of 3D Technologies (3DT) organization
Notable Customers
Research institutions and pharmaceutical companies using Merck's bioprinting solutions include Harvard University, MIT, Johnson & Johnson, and Roche, as referenced in case studies and collaborations for drug development and tissue engineering applications.